INTERNATIONAL STEM CELL CORPORATION (ISCO) Free cash flow 2016–2025
INTERNATIONAL STEM CELL CORPORATION (ISCO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$35,000FY2025 · since FY2016: -$4.4M → -$35,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35,000 | +77.1% |
| FY2024 | -$153,000 | -118.0% |
| FY2023 | $849,000 | +156.5% |
| FY2022 | $331,000 | +125.1% |
| FY2021 | -$1.3M | -257.7% |
| FY2020 | -$369,000 | +76.4% |
| FY2019 | -$1.6M | -23.2% |
| FY2018 | -$1.3M | +43.8% |
| FY2017 | -$2.3M | +49.1% |
| FY2016 | -$4.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ISCO financial trends
ISCO RevenueISCO Net incomeISCO Net marginISCO Gross profitISCO Gross marginISCO Operating incomeISCO Operating marginISCO Operating cash flowISCO Capital expendituresISCO Return on equityISCO Stock buybacksISCO Dividends paidISCO Total assetsISCO Total liabilitiesISCO Shareholders’ equityISCO overview →